August 27, 2025
Sana Biotechnology to Present at September 2025 Investor Conferences
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor…
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
Seasoned life sciences legal executive brings extensive public company experience, including broad strategic and financial transaction expertiseSAN DIEGO, Aug. 26,…
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its…
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company…
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that…
Study designed to assess safety and antitumor activity; data intended to inform a planned randomized Phase 2 studyTAMPA, Fla., Aug.…
– U.S. IND filing planned for Q4 2025 with U.S. enrollment expected to start in Q1 2026 – Patient dosing expected…
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is…